News & Events
Pharmaceutical Co-payments Now More Affordable for Patients with Cervical Cancer
The Co-Pay Relief program now offers funds to help patients afford treatment associated with the selective absence of fat from various parts of the body.
Co-Pay Relief Program supports patients with Non-Small Cell Lung Cancer who have an identified Molecular Biomarker and are on targeted therapy.
The second oldest co-pay assistance program in America, CPR has provided patients with over $200 million in direct financial assistance to help with copayment costs since inception.
The launch of the CPR Silo for Hepatitis C patients will provide financial assistance to those who need help affording their pharmaceutical medications and treatments.
CPR helps make pharmaceutical co-payments now more affordable for patients with metastatic gastric cancer
Co-Pay Relief’s parent organization is recognized with near-perfect rating awarded for “Financial Performance, Accountability and Transparency”
Patient Advocate Foundation Announces $3 Million Donation to its Co-Pay Relief (CPR) ProgramAdditional Funding to CPR Program Will Serve Chemotherapy Induced Neutropenia Patients in Need of Financial Assistance
HAMPTON, VA (February 4, 2013) - Patient Advocate Foundation (PAF) announced today its formation of a new Castrate Resistant Prostate Cancer Silo within its Co-Pay Relief (CPR) program
Multi-Year Donation to PAF Ensures Ongoing Co-Pay Assistance for Osteoporosis Patients December 11, 2012Web posted by PAF